81 related articles for article (PubMed ID: 24914571)
1. Alloantibody to a Bw4 epitope in a Bw4+B*27: 05 patient.
Lutz CT; Al-Attar A; May JR; Jennings CD
Transplantation; 2014 Oct; 98(8):853-6. PubMed ID: 24914571
[TBL] [Abstract][Full Text] [Related]
2. Three-dimensional structural modelling and calculation of electrostatic potentials of HLA Bw4 and Bw6 epitopes to explain the molecular basis for alloantibody binding: toward predicting HLA antigenicity and immunogenicity.
Mallon DH; Bradley JA; Winn PJ; Taylor CJ; Kosmoliaptsis V
Transplantation; 2015 Feb; 99(2):385-90. PubMed ID: 25606786
[TBL] [Abstract][Full Text] [Related]
3. Public epitope specificity of HLA class I antibodies induced by a failed kidney transplant: alloantibody characterization by flow cytometric techniques.
Piazza A; Poggi E; Ozzella G; Borrelli L; Monaco PI; Scornajenghi A; Tisone G; Adorno D
Transplantation; 2006 May; 81(9):1298-305. PubMed ID: 16699458
[TBL] [Abstract][Full Text] [Related]
4. Bw4-reactive and Bw6-reactive antibodies recognize multiple distinct HLA structures that partially overlap in the alpha-1 helix.
Lutz CT; Smith KD; Greazel NS; Mace BE; Jensen DA; McCutcheon JA; Goeken NE
J Immunol; 1994 Nov; 153(9):4099-110. PubMed ID: 7523516
[TBL] [Abstract][Full Text] [Related]
5. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor.
Gumperz JE; Litwin V; Phillips JH; Lanier LL; Parham P
J Exp Med; 1995 Mar; 181(3):1133-44. PubMed ID: 7532677
[TBL] [Abstract][Full Text] [Related]
6. Human leukocyte antigen Bw4 and Bw6 epitopes recognized by antibodies and natural killer cells.
Lutz CT
Curr Opin Organ Transplant; 2014 Aug; 19(4):436-41. PubMed ID: 24977435
[TBL] [Abstract][Full Text] [Related]
7. Unexpected Bw4 and Bw6 reactivity patterns in new alleles.
Voorter CE; van der Vlies S; Kik M; van den Berg-Loonen EM
Tissue Antigens; 2000 Oct; 56(4):363-70. PubMed ID: 11098937
[TBL] [Abstract][Full Text] [Related]
8. High-resolution, three-dimensional modeling of human leukocyte antigen class I structure and surface electrostatic potential reveals the molecular basis for alloantibody binding epitopes.
Kosmoliaptsis V; Dafforn TR; Chaudhry AN; Halsall DJ; Bradley JA; Taylor CJ
Hum Immunol; 2011 Nov; 72(11):1049-59. PubMed ID: 21840357
[TBL] [Abstract][Full Text] [Related]
9. The clinical importance of variation within the HLA-Bw4 complex.
Collins RW; Harmer AW; Heads AJ; Kondeatis E; Page G; Vaughan RW
Transplantation; 2001 Dec; 72(11):1851-3. PubMed ID: 11740403
[TBL] [Abstract][Full Text] [Related]
10. Characterization of a monoclonal anti-Bw4 antibody (Tü109): evidence for similar epitopes on the Bw4 and Bw6 antigens.
Müller C; Herbst H; Uchanska-Ziegler B; Ziegler A; Schunter F; Steiert I; Muller C; Wernet P
Hum Immunol; 1985 Dec; 14(4):333-49. PubMed ID: 2416720
[TBL] [Abstract][Full Text] [Related]
11. T cell can recognize the allospecificities formed by the substitution of amino acids associated with HLA-Bw4/Bw6 public epitopes.
Hiraiwa M; Yamamoto J; Matsumoto K; Karaki S; Nagao T; Kano K; Takiguchi M
Hum Immunol; 1991 Sep; 32(1):41-5. PubMed ID: 1723061
[TBL] [Abstract][Full Text] [Related]
12. Human leukocyte antigen-B (-Bw6/-Bw4 I80, T80) and human leukocyte antigen-C (-C1/-C2) subgrouping using pyrosequence analysis.
Ugolotti E; Vanni I; Raso A; Benzi F; Malnati M; Biassoni R
Hum Immunol; 2011 Oct; 72(10):859-68. PubMed ID: 21664941
[TBL] [Abstract][Full Text] [Related]
13. Expression of an unusual Bw4 epitope by a subtype of HLA-B8 [B*0802].
Arnett KL; Adams EJ; Gumperz JE; Darke C; Marsh SG; Gelsthorpe K; Parham P
Tissue Antigens; 1995 Oct; 46(4):316-21. PubMed ID: 8560451
[TBL] [Abstract][Full Text] [Related]
14. What goes around comes around.
Gebel HM
Transplantation; 2014 Oct; 98(8):817-8. PubMed ID: 25029388
[No Abstract] [Full Text] [Related]
15. The primary structure of HLA-A32 suggests a region involved in formation of the Bw4/Bw6 epitopes.
Wan AM; Ennis P; Parham P; Holmes N
J Immunol; 1986 Dec; 137(11):3671-4. PubMed ID: 2431040
[TBL] [Abstract][Full Text] [Related]
16. Epitope-specificities of HLA antibodies: the effect of epitope structure on Luminex technique-dependent antibody reactivity.
Resse M; Paolillo R; Minucci BP; Cavalca F; Casamassimi A; Napoli C
Hum Immunol; 2015 Apr; 76(4):297-300. PubMed ID: 25700961
[TBL] [Abstract][Full Text] [Related]
17. Epitope mapping of HLA-B27 and HLA-B7 antigens by using intradomain recombinants.
Toubert A; Raffoux C; Boretto J; Sire J; Sodoyer R; Thurau SR; Amor B; Colombani J; Lemonnier FA; Jordan BR
J Immunol; 1988 Oct; 141(7):2503-9. PubMed ID: 2459214
[TBL] [Abstract][Full Text] [Related]
18. HLA class I epitopes: recognition of binding sites by mAbs or eluted alloantibody confirmed with single recombinant antigens.
El-Awar N; Lee JH; Tarsitani C; Terasaki PI
Hum Immunol; 2007 Mar; 68(3):170-80. PubMed ID: 17349872
[TBL] [Abstract][Full Text] [Related]
19. Positive virtual crossmatch with negative flow crossmatch results in two cases.
Jacob EK; De Goey SR; Gandhi MJ
Transpl Immunol; 2011 Jul; 25(1):77-81. PubMed ID: 21641997
[TBL] [Abstract][Full Text] [Related]
20. Conserved and variable residues within the Bw4 motif of HLA-B make separable contributions to recognition by the NKB1 killer cell-inhibitory receptor.
Gumperz JE; Barber LD; Valiante NM; Percival L; Phillips JH; Lanier LL; Parham P
J Immunol; 1997 Jun; 158(11):5237-41. PubMed ID: 9164941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
